Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | PF562271 | 0.100 | 1.000 | uM | 72 | hr | 3 | 3938 | 129 | 0.2072 | 0.3018 | 0.0328 | 0.0284 |
A-375 | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 1 | 1428 | 152 | 0.0694 | 0.0541 | 0.1064 | 0.1374 |
A-375 | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 2 | 1035 | 164 | 0.0474 | 0.0541 | 0.1585 | 0.1374 |
A-375 | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 3 | 978 | 144 | 0.0454 | 0.0541 | 0.1472 | 0.1374 |
A-375 | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 1 | 4486 | 104 | 0.2384 | 0.2505 | 0.0232 | 0.0221 |
A-375 | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 2 | 5069 | 97 | 0.2705 | 0.2505 | 0.0191 | 0.0221 |
A-375 | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 3 | 4571 | 110 | 0.2427 | 0.2505 | 0.0241 | 0.0221 |
A-375 | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 1 | 3603 | 70 | 0.1922 | 0.1991 | 0.0194 | 0.0233 |
A-375 | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 2 | 3786 | 100 | 0.2005 | 0.1991 | 0.0264 | 0.0233 |
A-375 | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 3 | 3852 | 93 | 0.2045 | 0.1991 | 0.0241 | 0.0233 |
A-375 | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 1 | 2803 | 103 | 0.1469 | 0.1343 | 0.0367 | 0.0352 |
A-375 | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 2 | 2749 | 83 | 0.1450 | 0.1343 | 0.0302 | 0.0352 |
A-375 | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 3 | 2124 | 82 | 0.1111 | 0.1343 | 0.0386 | 0.0352 |
A-375 | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 1 | 984 | 182 | 0.0436 | 0.0432 | 0.1850 | 0.2026 |
A-375 | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 2 | 1030 | 203 | 0.0450 | 0.0432 | 0.1971 | 0.2026 |
A-375 | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 3 | 975 | 220 | 0.0411 | 0.0432 | 0.2256 | 0.2026 |
A-375 | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 1 | 3658 | 157 | 0.1904 | 0.1949 | 0.0429 | 0.0429 |
A-375 | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 2 | 3859 | 158 | 0.2013 | 0.1949 | 0.0409 | 0.0429 |
A-375 | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 3 | 3713 | 167 | 0.1929 | 0.1949 | 0.0450 | 0.0429 |
A-375 | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 1 | 2836 | 146 | 0.1463 | 0.1363 | 0.0515 | 0.0481 |
A-375 | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 2 | 2552 | 108 | 0.1329 | 0.1363 | 0.0423 | 0.0481 |
A-375 | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 3 | 2509 | 127 | 0.1296 | 0.1363 | 0.0506 | 0.0481 |
A-375 | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 1 | 2147 | 140 | 0.1092 | 0.0988 | 0.0652 | 0.0671 |
A-375 | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 2 | 1981 | 146 | 0.0998 | 0.0988 | 0.0737 | 0.0671 |
A-375 | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 3 | 1711 | 107 | 0.0873 | 0.0988 | 0.0625 | 0.0671 |